statements

The stock has been placed in Graded Surveillance Measure (GSM) list GSM - 0.

Prism Medico and Pharmacy Ltd.

BSE: 512217

Sector: Financial Services

Industry Group: Finance

Industry: Non Banking Financial Company (NBFC)

28.90+1.9 (+7.12%)

27 Jul, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Prism Medico and Pharmacy Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	TTM Dec 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	0.03	-	-	-	0.09	5.27	22.80	54.43	26.89	16.76	8.44	1.27	2.93	0.63	2.23
Cost of Operating Revenue	0.04	0.01	0.00	0.01	0.09	4.34	21.73	53.62	26.63	16.68	8.64	1.15	2.57	0.45	1.37
Gross Profit	-0.01	-0.01	0.00	-0.01	-0.01	0.93	1.08	0.81	0.26	0.08	-0.19	0.12	0.36	0.18	0.87
Gross Margin	-20.0	-	-	-	-10.1	17.7	4.7	1.5	1.0	0.5	-2.3	9.7	12.3	28.4	38.8
Total Operating Expenses	0.19	0.25	0.05	0.06	0.16	5.42	22.41	54.71	26.96	16.94	8.94	1.37	3.07	0.71	1.69
Operating Profit	-0.16	-0.25	-0.05	-0.06	-0.07	-0.15	0.39	-0.29	-0.07	-0.17	-0.50	-0.10	-0.14	-0.08	0.54
Operating Margin	-479.5	-	-	-	-85.3	-2.8	1.7	-0.5	-0.3	-1.0	-5.9	-8.2	-4.9	-12.8	24.4
Financing Income/(Expense) - Net	0.00	0.00	0.00	0.00	0.00	-0.14	-0.29	-0.11	0.00	0.00	0.00	0.00	-0.01	0.00	0.00
Profit before Taxes	-0.10	-0.19	-0.05	-0.01	-0.01	-0.21	0.07	-0.10	-0.07	-0.18	-0.50	-0.10	-0.03	-0.07	0.58
Income Taxes	-	-	-	-	-	0.01	0.07	-0.14	-0.02	-0.05	-0.13	-0.03	0.01	-0.02	-0.01
Profit after Tax	-0.10	-0.19	-0.05	-0.01	-0.01	-0.22	0.00	0.04	-0.05	-0.13	-0.37	-0.08	-0.03	-0.05	0.59
PAT Margin	-308.6	-	-	-	-9.8	-4.2	-	0.1	-0.2	-0.8	-4.4	-6.0	-1.2	-7.7	26.2
EPS - Basic - ex Extraordinary Items	-0.50	-0.94	-0.25	-0.05	-0.04	-0.37	-0.01	0.07	-0.08	-0.21	-0.61	-0.13	-0.06	-0.08	0.96
EPS - Diluted - ex Extraordinary Items	-0.50	-0.94	-0.25	-0.05	-0.04	-0.37	-0.01	0.07	-0.08	-0.21	-0.61	-0.13	-0.06	-0.08	0.96
EBIT	-0.16	-0.25	-0.05	-0.06	-0.07	-0.15	0.39	-0.29	-0.07	-0.17	-0.50	-0.10	-0.14	-0.08	0.54
EBITDA	-0.15	-0.24	-0.04	-0.06	-0.06	0.06	0.84	0.10	-0.05	-0.16	-0.49	-0.10	-0.14	-0.08	0.55
EBITDA Margin	-453.4	-	-	-	-74.2	1.1	3.7	0.2	-0.2	-1.0	-5.8	-7.6	-4.7	-12.1	24.5

Balance Sheet

Abridged

Understanding Balance Sheet

Prism Medico and Pharmacy Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	1.94	1.76	1.64	1.67	5.72	7.30	3.83	10.84	19.56	19.49	12.34	15.14	14.99	15.27
Long-Term Investments	-	-	-	-	0.02	0.02	2.63	1.38	1.94	1.94	-	-	-	-
Property Plant & Equipment - Net	0.03	0.03	0.02	0.01	7.60	9.91	9.31	8.91	0.07	0.06	0.05	0.04	0.03	0.03
Total Non-Current Assets	0.03	0.03	0.02	0.01	9.61	9.96	11.97	10.37	2.02	2.05	0.23	0.25	0.25	0.30
Total Assets	1.97	1.78	1.66	1.68	15.34	17.26	15.80	21.20	21.58	21.54	12.57	15.39	15.24	15.56
Total Current Liabilities	0.09	0.09	0.02	0.05	2.12	1.40	2.83	8.27	8.53	8.62	0.02	0.23	0.10	0.47
Long Term Debt	-	-	-	-	2.85	2.99	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	2.85	2.99	0.10	0.03	-	-	-	-	-	0.00
Total Liabilities	0.09	0.09	0.02	0.05	4.98	4.39	2.93	8.29	8.53	8.62	0.02	0.23	0.10	0.47
Total Shareholders' Equity	1.88	1.70	1.64	1.64	10.36	12.88	12.87	12.91	13.06	12.93	12.55	15.16	15.14	15.09
Total Equity	1.88	1.70	1.64	1.64	10.36	12.88	12.87	12.91	13.06	12.93	12.55	15.16	15.14	15.09
Total Liabilities & Equity	1.97	1.78	1.66	1.68	15.34	17.26	15.80	21.20	21.58	21.54	12.57	15.39	15.24	15.56

Cash Flow

Abridged

Understanding Cash Flow Statement

Prism Medico and Pharmacy Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	-0.09	-0.08	-0.05	0.00	0.00	-0.17	-	-	-20.24	-0.16	-0.49	2.59	-0.02	-0.06
Working Capital - Increase/(Decrease)	0.06	0.00	0.01	0.01	0.05	-0.54	-	-	15.87	0.11	-1.89	0.37	0.01	0.04
Net CF from Operating Activities	-0.04	-0.08	-0.04	0.01	0.05	-0.71	3.26	-0.44	-4.37	-0.05	-2.38	2.95	-0.01	-0.02
Capital Expenditures - Net	-	-	-	-	-	0.02	-0.08	-	-	-	-	-	-	-
Net CF from Investing Activities	-	0.08	0.03	0.00	0.46	-0.02	-2.53	-	4.36	0.02	2.35	-2.91	-	-
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	1.33	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-	-	-	0.02	0.05	-0.15	-1.33	-0.50	-	-	-	-	-	-
Net Cash Flow from Financing Activities	-	-	-	0.02	0.05	1.19	-1.33	-0.50	-	-	-	-	-	-
Cash Receipts - Business Activities	-	-	-	-	-	-	22.88	17.70	-	-	-	-	-	-
Cash Payments - Business Activities	-	-	-	-	-	-	0.64	0.83	-	-	-	-	-	-
Free Cash Flow to Equity	-0.04	-0.08	-0.04	0.03	0.10	-0.87	2.01	-0.94	-4.37	-	-	-	-	-
Free Operating CF net dividend	-0.04	-0.08	-0.04	0.01	0.05	-0.73	3.26	-0.44	-4.37	-0.05	-2.38	2.95	-0.01	-0.02
Free Operating CF	-0.04	-0.08	-0.04	0.01	0.05	-0.73	3.26	-0.44	-4.37	-0.05	-2.38	2.95	-0.01	-0.02

Business Segment Analysis

Prism Medico and Pharmacy Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Prism Medico and Pharmacy Ltd.

Regional Segment Analysis

Prism Medico and Pharmacy Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Prism Medico and Pharmacy Ltd.

Historical Segment Analysis

Track how Prism Medico and Pharmacy Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Prism Medico and Pharmacy Ltd.

Frequently Asked Questions

What is the revenue of Prism Medico and Pharmacy Ltd.?

The latest trailing twelve month revenue of Prism Medico and Pharmacy Ltd. is ₹ 2.23 Cr, reflecting a 1-year growth of 217.22% and a 3-year CAGR of -35.80%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Prism Medico and Pharmacy Ltd.?

The latest trailing twelve month net profit (PAT) of Prism Medico and Pharmacy Ltd. is ₹ 0.58 Cr, with a 3-year earnings CAGR of 49.13%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Prism Medico and Pharmacy Ltd.?

The trailing twelve month EBITDA of Prism Medico and Pharmacy Ltd. is approximately ₹ 0.54 Cr (based on an operating margin of 24.37%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Prism Medico and Pharmacy Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Prism Medico and Pharmacy Ltd. is 0.96. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Prism Medico and Pharmacy Ltd.?

The debt-to-equity ratio of Prism Medico and Pharmacy Ltd. stands at 0.00. The interest coverage ratio is -47.41x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Prism Medico and Pharmacy Ltd.?

The estimated book value per share of Prism Medico and Pharmacy Ltd. is 24.89 (derived from a P/B ratio of 1.16 and market price of ₹ 28.90), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Prism Medico and Pharmacy Ltd.?

The trailing twelve month operating cash flow of Prism Medico and Pharmacy Ltd. is ₹ -0.02 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Prism Medico and Pharmacy Ltd. report consolidated or standalone financials?

Prism Medico and Pharmacy Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.